In mid-2026, the Department of Justice announced its largest coordinated health care fraud enforcement action in history, charging more than 450 defendants — including 90 physicians and other licensed medical professionals — in schemes involving upward of $14.6 billion in alleged false claims, according to DOJ and Department of Health and Human Services materials describing the operation.DOCUMENTED
The scale of the coordinated action is itself unusual. Reported figures for the takedown vary somewhat depending on which related actions and time windows are counted, ranging from roughly $6.5 billion to $14.6 billion in alleged false claims across more than 450 to 455 defendants — a range that reflects the difficulty of cleanly bounding a single nationwide enforcement sweep that folded in dozens of separately filed cases across multiple U.S. Attorney's offices.REVIEWED
- More than 450 defendants were charged, including 90 physicians and other licensed medical professionals — a notably high proportion of credentialed providers among the accused.
- A notable individual case involved a defendant accused of directing kickback-driven use of wound-care "allografts" on hospice patients — applied, prosecutors allege, without coordination with treating physicians and to wounds that did not need the treatment.
- That defendant allegedly received over $24 million from the arrangement, which prosecutors say was spent on a Ferrari, a Bulgari necklace, and a multimillion-dollar home in Hawaii.
- The operation included a newly deployed Health Care Fraud Data Fusion Center using predictive analytics across federal and state agencies to identify anomalous billing patterns.
- Separately reported enforcement in the same window included a $10.6 billion transnational Medicare fraud scheme and a $650 million Arizona Medicaid scheme, plus international arrests in Cyprus, Estonia, and the Philippines tied to related fraud networks.
- Civil enforcement in the same sweep included charges against 20 defendants involving $14.2 million in alleged fraud and settlements with 106 defendants totaling $34.3 million.
The mechanism: billing for care that wasn't needed
Much of the enforcement action centers on a specific, recurring pattern: expensive treatments — wound-care products, genetic tests, durable medical equipment — administered or billed regardless of medical necessity, driven by kickback payments to the providers who order them. The DOJ's own description of the hospice wound-care case is explicit that the treatment was applied "without coordination with the patients' treating physicians" and to wounds that "did not need this treatment," language that describes a scheme built around billing volume rather than patient care.DOCUMENTED
These lucrative kickbacks allegedly caused the defendant and others to target hospice patients and apply the allografts without coordination with the patients' treating physicians, without proper treatment for infection, to superficial wounds that did not need this treatment, and to areas that far exceeded the size of the wound.
The choice of hospice patients as a target population is significant beyond the dollar figures involved. Hospice patients are, by definition, near the end of life and often unable to closely monitor or question the specifics of their own treatment, and their families are frequently focused on comfort and quality of remaining time rather than auditing billing codes — circumstances that, according to the pattern DOJ describes, made this population a particularly exploitable source of fraudulent billing volume.
Why the scale keeps growing
Year-over-year enforcement totals in this space have grown substantially, which prosecutors and compliance analysts attribute partly to improved data-driven detection — cross-referencing billing patterns across Medicare, Medicaid, and private insurers to flag statistically anomalous providers before a whistleblower ever comes forward. The newly announced Health Care Fraud Data Fusion Center is explicitly framed by DOJ as an investment in this direction: using predictive analytics and coordinated federal-state data-sharing to identify enterprise-wide fraud schemes earlier in their operation.REVIEWED
Separately, ordinary False Claims Act settlements continue alongside the major coordinated takedown, illustrating that health care fraud enforcement operates simultaneously at two very different scales. DOJ announced in mid-2026 that laboratory executives, marketers, and a physician agreed to pay over $2 million to resolve allegations of kickbacks to doctors disguised as investment distributions from a managed service organization — part of more than $61 million in similar recoveries the department has secured since 2019 for this specific kickback structure alone.DOCUMENTED
What this means for the health care system
The dollar figures involved in health care fraud enforcement are large enough that they meaningfully affect the sustainability of public health programs — every dollar billed fraudulently to Medicare or Medicaid is, in aggregate, a dollar not available for legitimate patient care within a program that operates on a fixed budget. The 2026 takedown's emphasis on data-driven detection, rather than solely reactive investigation following whistleblower complaints, suggests federal enforcement is attempting to shift from cleaning up after large-scale fraud schemes have already extracted hundreds of millions of dollars, toward identifying them earlier in their operation — though the continued growth in total dollar figures each year suggests that shift remains a work in progress.
Sources behind this report
Have documents relevant to this story? Reach us through our tips channel.